DermaBio
DermaBio delivers AI-based precision medicine via skin biomarkers and predictive modeling.
StartupDermaBio is a Jerusalem-based startup in the Health Tech & Life Sciences sector, established in 2022. DermaBio delivers AI-based precision medicine via skin biomarkers and predictive modeling.. DermaBio was founded by Miriam Oron Ph.D. and Meital Portugal. Key investors include MindUP. The company has 1-10 employees. Core technologies: Artificial Intelligence, Machine Learning, Platforms & Interfaces, Software.
The company follows a B2B business model. Product stage: Clinical Trial. The company holds 1 patent.
- StagePre-Seed
- ProductClinical Trial
- ModelB2B
- Employees1-10
- HQJerusalem
- DistrictJerusalem District
- Last RoundUndisclosed
- MindUPLead
Miriam Oron Ph.D.Co-founder & CEO
Meital PortugalCo-founder & CTO
What does DermaBio do?
The Future of Precision Medicine Starts with Your Skin Today, prescribing biologic drugs is a costly guessing game — one that’s growing rapidly as biologics are set to become the standard of care across many diseases. Trial and error treatment leads to wasted time, poor outcomes, and skyrocketing healthcare costs. DermaBio is changing this. Our AI-powered precision medicine platform combines skin biomarker analysis, a proprietary clinical assay, and advanced data modeling to predict response to biologic therapies. This empowers smarter, faster, and more cost-effective care across multiple diseases. Our data driven platform combines clinical assays and advanced data modeling to predict response from skin biomarker analysis. Our non-invasive skin swab integrates seamlessly into clinical workflows—fast, painless, and patient-friendly. Clinicians and payers get actionable data. In short: One versatile platform. A win for clinicians, patients and payers.
Who founded DermaBio?
DermaBio was founded in 2022 by Miriam Oron Ph.D. (Co-founder & CEO), Meital Portugal (Co-founder & CTO).
What sector is DermaBio in?
DermaBio operates in Health Tech & Life Sciences, Digital Healthcare, Medical Decision Support, with core technologies in Artificial Intelligence, Machine Learning, Platforms & Interfaces, Software. Target customers: Healthcare & Life Sciences, Healthcare, Laboratories, Providers, Insurance Companies.
Where is DermaBio located?
DermaBio is based in Jerusalem, Israel, Jerusalem District. The company also has offices abroad.